MEK/ERK inhibitors may become a new type of drug for the treatment of Ems.32–34 Simon et al35 found in oral cancer research that the MEK/ERK pathway is activated in oral cancer cells. Here, MAP2K7 is linked to eosinophilia-myalgia syndrome.